Health Canada Panel Report Could Spur Behind-The-Counter Ibuprofen
This article was originally published in The Tan Sheet
Executive Summary
Ibuprofen products in Canada will carry enhanced cardiovascular risk labeling and could end up behind the counter following a report from Health Canada's Expert Advisory Panel on COX-2s